214 related articles for article (PubMed ID: 20100931)
1. CD72 negatively regulates KIT-mediated responses in human mast cells.
Kataoka TR; Kumanogoh A; Bandara G; Metcalfe DD; Gilfillan AM
J Immunol; 2010 Mar; 184(5):2468-75. PubMed ID: 20100931
[TBL] [Abstract][Full Text] [Related]
2. CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.
Kataoka TR; Kumanogoh A; Hirata M; Moriyoshi K; Ueshima C; Kawahara M; Tsuruyama T; Haga H
Sci Rep; 2013 Oct; 3():2861. PubMed ID: 24713856
[TBL] [Abstract][Full Text] [Related]
3. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.
Kataoka TR; Kumanogoh A; Fukuishi N; Ueshima C; Hirata M; Moriyoshi K; Tsuruyama T; Haga H
Int Immunol; 2015 Feb; 27(2):95-103. PubMed ID: 25239131
[TBL] [Abstract][Full Text] [Related]
4. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
5. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.
Wu HJ; Bondada S
J Clin Immunol; 2009 Jan; 29(1):12-21. PubMed ID: 19067131
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.
Ishida I; Kumanogoh A; Suzuki K; Akahani S; Noda K; Kikutani H
Int Immunol; 2003 Aug; 15(8):1027-34. PubMed ID: 12882840
[TBL] [Abstract][Full Text] [Related]
7. CD72 negatively regulates signaling through the antigen receptor of B cells.
Adachi T; Wakabayashi C; Nakayama T; Yakura H; Tsubata T
J Immunol; 2000 Feb; 164(3):1223-9. PubMed ID: 10640734
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
9. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
[TBL] [Abstract][Full Text] [Related]
10. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
11. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation.
Tkaczyk C; Horejsi V; Iwaki S; Draber P; Samelson LE; Satterthwaite AB; Nahm DH; Metcalfe DD; Gilfillan AM
Blood; 2004 Jul; 104(1):207-14. PubMed ID: 15010370
[TBL] [Abstract][Full Text] [Related]
12. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of mast cell proliferation by FcgammaRIIB.
Malbec O; Attal JP; Fridman WH; Daëron M
Mol Immunol; 2002 Sep; 38(16-18):1295-9. PubMed ID: 12217398
[TBL] [Abstract][Full Text] [Related]
14. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
Rottem M; Okada T; Goff JP; Metcalfe DD
Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
[TBL] [Abstract][Full Text] [Related]
15. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
Kumanogoh A; Shikina T; Watanabe C; Takegahara N; Suzuki K; Yamamoto M; Takamatsu H; Prasad DV; Mizui M; Toyofuku T; Tamura M; Watanabe D; Parnes JR; Kikutani H
Int Immunol; 2005 Oct; 17(10):1277-82. PubMed ID: 16113236
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells.
Sawada J; Shimizu S; Tamatani T; Kanegasaki S; Saito H; Tanaka A; Kambe N; Nakahata T; Matsuda H
J Immunol; 2005 Mar; 174(6):3626-32. PubMed ID: 15749900
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
18. Association of 3BP2 with SHP-1 regulates SHP-1-mediated production of TNF-α in RBL-2H3 cells.
Chihara K; Nakashima K; Takeuchi K; Sada K
Genes Cells; 2011 Dec; 16(12):1133-45. PubMed ID: 22077594
[TBL] [Abstract][Full Text] [Related]
19. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
[TBL] [Abstract][Full Text] [Related]
20. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.
Timokhina I; Kissel H; Stella G; Besmer P
EMBO J; 1998 Nov; 17(21):6250-62. PubMed ID: 9799234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
